Nexalin Technology (NXL) Return on Sales (2021 - 2026)
Nexalin Technology has reported Return on Sales over the past 5 years, most recently at 0.14% for Q4 2025.
- For Q4 2025, Return on Sales rose 90.0% year-over-year to 0.14%; the TTM value through Dec 2025 reached 0.27%, up 18.0%, while the annual FY2025 figure was 0.27%, 18.0% up from the prior year.
- Return on Sales for Q4 2025 was 0.14% at Nexalin Technology, up from 1.25% in the prior quarter.
- Over five years, Return on Sales peaked at 0.01% in Q3 2022 and troughed at 1.25% in Q3 2025.
- A 5-year average of 0.39% and a median of 0.25% in 2021 define the central range for Return on Sales.
- Biggest five-year swings in Return on Sales: tumbled -95bps in 2023 and later skyrocketed 90bps in 2025.
- Year by year, Return on Sales stood at 0.25% in 2021, then grew by 23bps to 0.19% in 2022, then crashed by -99bps to 0.38% in 2023, then crashed by -174bps to 1.04% in 2024, then soared by 87bps to 0.14% in 2025.
- Business Quant data shows Return on Sales for NXL at 0.14% in Q4 2025, 1.25% in Q3 2025, and 0.22% in Q2 2025.